Dextromethorphan Hydrobromide, Guaifenesin by Innovida Pharmaeutique Corporation
Dextromethorphan Hydrobromide, Guaifenesin by
Drug Labeling and Warnings
Dextromethorphan Hydrobromide, Guaifenesin by is a Otc medication manufactured, distributed, or labeled by Innovida Pharmaeutique Corporation. Drug facts, warnings, and ingredients follow.
Drug Details [pdf]
DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN- dextromethorphan hydrobromide, guaifenesin liquid
Innovida Pharmaeutique Corporation
----------
Uses
temporarily relieves cough due to minor throat and bronchial irritation as may occur with a cold
helps loosen phlegm (mucus) and thin bronchial secretions to drain bronchial tubes
Warnings
Do not use
if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
Ask a doctor before use if you have
cough that occurs with too much phlegm (mucus)
cough that lasts or is chronic such as occurs with smoking, asthma, chronic bronchitis, or emphysema
Stop use and ask a doctor if
cough lasts for more than 7 days, comes back, or is accompanied by fever, rash, or persistent headache. A persistent cough may be a sign of a serious condition.
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
Directions
do not take more than 6 doses in any 24-hour period
measure only with dosing cup provided
keep dosing cup with product
mL = milliliter
this adult product is not intended for use in children under 12 years of age
| age | dose |
| adults and children 12 years and over | 20 mL every 4 hours |
| children under 12 years | do not use |
| DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN
dextromethorphan hydrobromide, guaifenesin liquid |
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
| Labeler - Innovida Pharmaeutique Corporation (080892908) |